BRCA1 and neoplasm: Thus, a therapeutic regimen that includes inhibitors for the DNA repair pathway, a tumor-specific platinum drug, together with radiotherapy may prove to be an effective way of treating and managing the cancer burden due to BRCA1 and BRCA2 mutations.